Lucid Diagnostics (LUCD) Equity Average (2020 - 2026)

Lucid Diagnostics has reported Equity Average for 7 years, with the latest figure at $7.5 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average rose 106585.71% year-over-year to $7.5 million; the trailing twelve-month figure through Mar 2026 stood at $7.5 million (up 106585.71% YoY), and the FY2025 full-year result was $8.2 million, up 430.1% from the prior year.
• Equity Average for Q1 2026 stood at $7.5 million, down from $18.4 million in the prior quarter.
• The five-year high for Equity Average was $50.6 million in Q1 2022, with the low at $7000.0 in Q1 2025.
• Historically, Equity Average has averaged $16.6 million across 5 years, with a median of $13.9 million in 2024.
• Annual changes were most pronounced in 2025 — Equity Average plunged 99.85% — and 2026, when it jumped 106585.71%.
• Lucid Diagnostics' Equity Average stood at $25.3 million in 2022, then tumbled by 99.52% to $122500.0 in 2023, then jumped by 4687.35% to $5.9 million in 2024, then soared by 213.5% to $18.4 million in 2025, then tumbled by 59.38% to $7.5 million in 2026.
• The last three Equity Average figures came in at $7.5 million (Q1 2026), $18.4 million (Q4 2025), and $16.8 million (Q3 2025), per Business Quant data.